USDTL

What USDTL does

USDTL (United States Drug Testing Laboratories, Inc.) is a privately held forensic and clinical toxicology reference laboratory founded in 1991 and headquartered in Des Plaines, Illinois, with a planned new state-of-the-art laboratory facility in Chicago. The company provides drug and alcohol testing services across hair, nail, umbilical cord tissue, meconium, urine, and dried blood spot specimens, organized around branded product lines including HairStat, NailStat, ChildGuard, CordStat / CordStat EtOH, MecStat / MecStat EtOH, PEthStat, and direct alcohol biomarker testing (EtG, EtS, FAEE, PEth). Its analytical platform is built on LCMSMS (liquid chromatography tandem mass spectrometry) technology, and it was the first laboratory in the world to receive ISO/IEC 17025 accreditation (ANAB, 2015) for drug and alcohol testing in umbilical cord, fingernail, and toenail specimens, alongside CAP, CLIA high-complexity, DEA, HIPAA, and multi-state clinical laboratory certifications.

The company serves hospitals, child protection agencies, the U.S. Department of Defense, legal services, rehabilitation and treatment centers, universities and research institutions, and other clinical and forensic laboratories through a sales-led B2B distribution model with account executives, a client services team, an online client portal, and free specimen collection supplies. Its customer segmentation is vertical-led, with primary segments in newborn/perinatal testing and adult/child testing, and secondary segments in court systems and legal services, healthcare professional monitoring, and research specimen testing. In January 2025 the company expanded from a forensic-only operation to also process clinical specimens, integrated with CourtFact's case management platform for legal workflow data exchange, and has aggressively expanded its novel psychoactive substance menu through 2024-2025 (ketamine, xylazine, psilocin, gabapentin, DXM, medetomidine, tianeptine, phenibut, kratom, SSRIs in cord tissue, expanded fentanyl across five specimen types, and extended cannabinoid panels in ChildGuard).

USDTL is a privately held, founder-influenced company. The first disclosed institutional capital event occurred on January 7, 2025 with Northlane Capital Partners as lead investor. Leadership includes President and Scientific Director Douglas Lewis, Executive Vice President Veronica Lewis, Vice President of Laboratory Operations Joseph Jones, Laboratory Directors Adam Negrusz, Ph.D., F-ABFT, and Donna Coy, Ph.D., NRCC-TC, plus a research and development team that publishes in the scientific literature and holds memberships in NDASA, SAPAA, CLMA, and other professional societies. Pricing is contact-based and not publicly disclosed, and revenue is not reported; the company generates professional-services revenue on a per-test basis across its forensic and (as of 2025) clinical specimen menus.

Name

USDTL

Legal name

United States Drug Testing Laboratories, Inc.

Website

https://usdtl.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

USDTL is a privately held forensic and clinical toxicology reference laboratory founded in 1991 in Des Plaines, Illinois, using LCMSMS technology to provide drug and alcohol testing across hair, nail, umbilical cord, meconium, urine, and dried blood spot specimens for hospitals, child protection agencies, the Department of Defense, legal services, and other laboratories.

Ownership category

akta.pro rank

Product category

Forensic and Clinical Toxicology Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Forensic & Anti-Counterfeit Testing (Product Integrity) (HLAGADAM), Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)

Keywords

• Forensic toxicology services
• Drug testing laboratory
• Alcohol biomarker testing
• Newborn drug screening
• Clinical toxicology testing

Headquarters

HQ city

Des Plaines

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: USDTL operates as a reference forensic toxicology laboratory providing drug and alcohol testing services. Services include newborn testing (umbilical cord, meconium), adult/child testing (hair, nail, urine, blood), and specialty biomarker testing. The company provides test collection supplies at no additional charge.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

USDTL (United States Drug Testing Laboratories, Inc.) is a reference forensic and clinical toxicology laboratory providing drug and alcohol testing services across multiple specimen types including hair, nail, umbilical cord tissue, meconium, urine, and dried blood spots. The laboratory delivers forensically defensible results with documented chain of custody to healthcare facilities, child protection agencies, government agencies, legal services, rehabilitation centers, and other clinical/forensic laboratories. Service includes free specimen collection supplies, online client portal access, and customizable test panels covering novel substances such as synthetic cannabinoids.

Product overview

USDTL (United States Drug Testing Laboratories, Inc.) is a forensic and clinical toxicology laboratory offering a comprehensive suite of drug and alcohol testing services organized around multiple specimen types. The portfolio includes HairStat and NailStat for hair and nail testing (with 17 drug panels in hair), ChildGuard for child environmental exposure testing, CordStat panels for umbilical cord tissue testing, Meconium Testing for newborns, Urine Drug Testing, and PEthStat for alcohol biomarker detection via dried blood spot. USDTL is the only commercial laboratory offering PEth testing via dried blood spot and was the first laboratory ISO/IEC 17025 accredited for umbilical cord, fingernail, and toenail testing worldwide. The company processes both forensic and clinical specimens and serves hospitals, child protection agencies, legal services, businesses, and government entities.

Differentiator

Problem solved

Functional benefit

Brands

• HairStat®: Hair drug testing service with screening and confirmation cutoffs
• NailStat®
• CordStat
• PEthStat
• MecStat EtOH
• ChildGuard®

Products and services

• HairStat (Hair Drug Testing) Hair drug testing service detecting substance abuse over an approximately 3-month window prior to collection. USDTL offers 17 drug panels in hair along with add-on tests—the widest breadth of hair testing profiles of any U.S. laboratory—and its marijuana metabolite assay is described as the most sensitive in the world. Used by healthcare, legal, child protection, and workplace testing clients.
• NailStat (Fingernail/Toenail Drug Testing) Fingernail and toenail drug testing service offering detection windows of approximately 3-6 months for most substances and up to 8 months for certain drugs. USDTL was the first ISO/IEC 17025 accredited laboratory for fingernail and toenail testing worldwide. Used by healthcare, legal, child protection, and workplace testing clients.
• ChildGuard (Child Environmental Exposure Hair Testing) Environmental drug exposure testing designed specifically for children, detecting both native drugs and drug metabolites from passive inhalation, contact with drug smoke, skin oils of drug users, or accidental ingestion. Extended cannabinoid panels are available for cases involving vulnerable populations. Used by child protection agencies, hospitals, and legal services.
• CordStat (Umbilical Cord Tissue Drug Testing) Umbilical cord tissue drug testing providing detection of substances over approximately 20 weeks prior to birth. Available in multiple panel configurations including CordStat 12 and CordStat 13, covering the majority of opioids and drugs commonly associated with neonatal abstinence syndrome (NAS). Used by hospitals, neonatology units, and child protection agencies.
• PEthStat (Phosphatidylethanol Alcohol Biomarker Testing) Phosphatidylethanol (PEth) alcohol biomarker test using dried blood spot cards, simplifying collection for non-medical organizations. Detection window is approximately 2-4 weeks prior to collection. Used by workplace monitoring programs, legal services, and rehabilitation centers.
• Meconium Drug Testing (MecStat) Drug and alcohol testing service using meconium (the first stool of a newborn), offering an approximately 20-week detection window prior to birth. USDTL requires a minimum of 3 grams of meconium for testing. Used by hospitals, neonatology units, and child protection agencies.
• Urine Drug Testing Urine-based drug and alcohol testing service, including ethyl glucuronide (EtG) and ethyl sulfate (EtS) detection, with a detection window of approximately 2-3 days prior to collection. Used by workplace, clinical, and legal testing clients.
• Direct Alcohol Biomarker Testing Suite Suite of long-term alcohol biomarker tests covering EtG (urine, hair, nail, umbilical cord tissue), EtS (urine), FAEE (meconium), and PEth (blood/dried blood spots). USDTL offers the most extensive testing for direct ethyl alcohol biomarkers of any laboratory in the world. Used by treatment centers, courts, child protection agencies, and workplace monitoring programs.

Quantifiable outcome

• Hair testing is 3.5x more likely to detect methamphetamine exposure than urine testing

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Partnerships

One partnership is on record.

• CourtFactcoreTechnology or IntegrationIntegration partnership announced to streamline case management and drug testing services. The partnership integrates USDTL's toxicology testing services with CourtFact's case management platform, enabling seamless data exchange between the two systems for court-related drug testing cases.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Millennium Health: Specialty clinical toxicology laboratory providing urine drug testing, oral fluid testing, and medication monitoring services. Directly comparable to USDTL in LCMSMS-based drug testing for pain management, addiction treatment, and behavioral health markets.
• Cordant Health Solutions: Specialty toxicology and behavioral health laboratory providing drug testing, monitoring, and pharmacy services for criminal justice, workplace, and healthcare customers. Comparable niche market overlap and reference laboratory model.
• Clinical Reference Laboratory (CRL): Independent reference laboratory offering a broad toxicology menu including drugs of abuse testing with healthcare provider clients. Directly comparable B2B reference laboratory operating model serving physicians and institutions.
• Pacific Toxicology Laboratories: Independent specialty toxicology reference laboratory providing drug testing, therapeutic monitoring, and forensic services on the U.S. West Coast. Comparable B2B toxicology model with multi-specimen testing menu, though regionally concentrated.
• Aegis Sciences Corporation: Specialty forensic and clinical toxicology laboratory offering drug and alcohol testing with hair, urine, and oral fluid specimen options. Closely comparable to USDTL's specialty toxicology focus and healthcare provider clientele.

Broad incumbents

• Quest Diagnostics: Largest U.S. clinical laboratory network offering a broad toxicology and drug testing menu as part of its general diagnostics portfolio. Overlaps with USDTL on drug testing but on a national, scaled, multi-specialty platform rather than specialty toxicology only.
• Laboratory Corporation of America (LabCorp): National clinical laboratory network offering workplace drug testing, pain management toxicology, and esoteric testing. Comparable on toxicology services but with vastly larger scope across routine clinical diagnostics.
• ARUP Laboratories: Academic-affiliated reference laboratory providing esoteric and specialty testing including clinical toxicology. Comparable on highly specialized toxicology offerings but with a broader esoteric and academic research focus.

Emerging players

• Dominion Diagnostics: Specialty laboratory focused on pain management and substance abuse toxicology testing using LCMSMS technology. Comparable niche toxicology platform and LCMSMS methodology for healthcare provider clients.
• Ethos Laboratories: Specialty toxicology laboratory offering drug and alcohol testing for healthcare and recovery-focused customers. Comparable clinical toxicology menu and physician-office customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/usdtl
• Xx.com/usdtl
• LinkedInlinkedin.com/company/641723

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about USDTL